ELOX offering history
Every offering-related filing in Eloxx Pharmaceuticals, Inc.’s recent SEC record — registrations (announced capacity) kept separate from pricing documents (executed sales). Reviewed 1,009 filings back to Nov 21, 2008.
| Date | Filing | What it means | |
|---|---|---|---|
| Jun 9, 2026 | 424B4 → | EXECUTED | Final prospectus — offering priced (typical for IPOs and marketed share deals) |
| Jun 8, 2026 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
| Jun 4, 2026 | S-1/A → | REGISTERED | S-1/A registration — capacity to sell shares, not a sale yet |
| Jun 1, 2026 | 8-K → | EXECUTED | Unregistered share sale disclosed (8-K item 3.02) |
| Jun 1, 2026 | S-1/A → | REGISTERED | S-1/A registration — capacity to sell shares, not a sale yet |
| May 7, 2026 | S-1 → | REGISTERED | S-1 registration — capacity to sell shares, not a sale yet |
| Jan 25, 2024 | S-3 → | REGISTERED | S-3 registration — capacity to sell shares, not a sale yet |
| Jan 9, 2024 | 8-K → | EXECUTED | Unregistered share sale disclosed (8-K item 3.02) |
| Sep 20, 2023 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| Sep 20, 2023 | 8-K → | EXECUTED | Unregistered share sale disclosed (8-K item 3.02) |
| Aug 11, 2023 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| May 24, 2023 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| May 6, 2022 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| Sep 30, 2021 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| Aug 30, 2021 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
| Aug 20, 2021 | S-3 → | REGISTERED | S-3 registration — capacity to sell shares, not a sale yet |
| May 17, 2021 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| May 13, 2021 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| Apr 1, 2021 | 8-K → | EXECUTED | Unregistered share sale disclosed (8-K item 3.02) |
| Jun 20, 2019 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| Jun 19, 2019 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| Nov 26, 2018 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
| Nov 16, 2018 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| Nov 16, 2018 | S-3 → | REGISTERED | S-3 registration — capacity to sell shares, not a sale yet |
| Apr 26, 2018 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| Apr 24, 2018 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| Apr 20, 2018 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
| Apr 10, 2018 | S-3 → | REGISTERED | S-3 registration — capacity to sell shares, not a sale yet |
| Dec 22, 2017 | 8-K → | EXECUTED | Unregistered share sale disclosed (8-K item 3.02) |
| Aug 3, 2017 | 8-K → | EXECUTED | Unregistered share sale disclosed (8-K item 3.02) |
| Feb 22, 2017 | 8-K → | EXECUTED | Unregistered share sale disclosed (8-K item 3.02) |
| Oct 31, 2016 | RW → | WITHDRAWN | Registration withdrawn |
| Oct 9, 2015 | S-1 → | REGISTERED | S-1 registration — capacity to sell shares, not a sale yet |
| Jul 31, 2015 | 8-K → | EXECUTED | Unregistered share sale disclosed (8-K item 3.02) |
| Jun 30, 2015 | 8-K → | EXECUTED | Unregistered share sale disclosed (8-K item 3.02) |
| Jun 16, 2015 | 8-K → | EXECUTED | Unregistered share sale disclosed (8-K item 3.02) |
| Jun 4, 2015 | 8-K → | EXECUTED | Unregistered share sale disclosed (8-K item 3.02) |
| May 11, 2015 | 8-K → | EXECUTED | Unregistered share sale disclosed (8-K item 3.02) |
| May 7, 2015 | 8-K → | EXECUTED | Unregistered share sale disclosed (8-K item 3.02) |
| Jun 16, 2014 | 8-K → | EXECUTED | Unregistered share sale disclosed (8-K item 3.02) |
Two honest limits. (1) A 424B takedown can price shares or notes— EDGAR’s metadata doesn’t say which, so open the document: large investment-grade filers use these mostly for bond deals (no dilution), small-caps mostly for shares. (2) At-the-market (ATM) programs sell shares gradually and individual sales are not separately filed — the visible footprint is the enabling shelf and its 424B5; actual ATM share counts surface later in the 10-Q/10-K share count. Educational information from public filings, not investment advice.
ELOX offering FAQ
When did ELOX last execute an offering?
Per SEC filings, Eloxx Pharmaceuticals, Inc.'s most recent priced offering document is a 424B4 filed 2026-06-09. Note a 424B takedown can price shares or notes (debt) — the linked document says which.
When did ELOX last announce or register an offering?
The most recent registration is a S-1/A filed 2026-06-04. A registration is capacity to sell shares — not a sale.
Does an offering always mean dilution?
Registered direct offerings and shelf takedowns issue new shares and dilute existing holders. Resale registrations (424B3/B7) let existing holders sell and do not create new shares. Secondary sales by insiders also do not dilute. Each row here is labeled with what it is.